These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3622592)

  • 1. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and the classical arthritides: focus on five-years of piroxicam experience.
    Calin A
    Eur J Rheumatol Inflamm; 1987; 8(1):24-30. PubMed ID: 3305035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
    Hobbs DC
    Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age on piroxicam disposition in rheumatoid arthritis.
    Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
    J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of piroxicam.
    Verbeeck RK; Richardson CJ; Blocka KL
    J Rheumatol; 1986 Aug; 13(4):789-96. PubMed ID: 3490574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics.
    Brune K
    Eur J Rheumatol Inflamm; 1987; 8(1):18-23. PubMed ID: 3622591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of non steroidal anti-inflammatory drugs in synovial fluid.
    Netter P; Bannwarth B; Lapicquel F; Demotes-Mainard F; Schceverbeke T; Gillet P
    Agents Actions Suppl; 1993; 44():45-50. PubMed ID: 8372734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency.
    Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L
    Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetic studies with lornoxicam.
    Turner P; Johnston A
    Postgrad Med J; 1990; 66 Suppl 4():S28-9. PubMed ID: 2284218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transsynovial kinetics and correlation of dosage and effect of non-steroidal anti-rheumatic agents].
    Fenner H
    Fortschr Med; 1982 Sep; 100(36):1642-6. PubMed ID: 6982842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
    Skjodt NM; Davies NM
    Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
    Thabe H; Fassbender HG; Laufen H; Gierend M
    Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats.
    Sigurdardottir SL; Freysdottir J; Vikingsdottir T; Valdimarsson H; Vikingsson A
    Scand J Rheumatol; 2008; 37(6):469-76. PubMed ID: 19005999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic characteristics as the basis for differential therapy using non-steroidal anti-inflammatory agents].
    Brune K
    Z Rheumatol; 1987; 46(1):13-8. PubMed ID: 3591020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs.
    Graham GG
    Med J Aust; 1987 Dec 7-21; 147(11-12):597-602. PubMed ID: 3320710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.